Brandywine Global Investment Management, LLC Rigel Pharmaceuticals Inc Transaction History

Brandywine Global Investment Management, LLC

  • $14.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.67 - $3.19 $130,248 - $620,136
-194,400 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$2.36 - $3.57 $150,367 - $227,462
-63,715 Reduced 24.68%
194,400 $515,000
Q3 2021

Nov 12, 2021
BUY
$3.5 - $4.5 $903,402 - $1.16 Million
258,115 New
258,115 $937,000

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $3.31B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email